Advertisement

Topics

AIM Pharmakon, Inc. Company Profile

23:09 EDT 18th June 2018 | BioPortfolio


News Articles [3 Associated News Articles listed on BioPortfolio]

Novocure enters $150mm loan financing; pays off existing debt

Novocure Ltd. (developed the Tumor Treating Fields alternating electrical field technology to treat cancer) entered into a $150mm non-dilutive term loan with BioPharma Credit PLC (managed by Pharmakon...

Novartis weitet Zusammenarbeit mit Science 37 aus

So hätten sich die beiden Unternehmen geeinigt, bis zu zehn klinische Studienprogramme in den kommenden drei Jahren zu starten, die auf eine verstärkte Dezentralisierung setzen, teilt der Pharmakon....

Novocure gets $150M boost in term loan agreement

A term loan agreement was reached by Novocure with BioPharma Credit, the investment fund of Pharmakon Advisors, for a term lo -More- 

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

More Information about "AIM Pharmakon, Inc." on BioPortfolio

We have published hundreds of AIM Pharmakon, Inc. news stories on BioPortfolio along with dozens of AIM Pharmakon, Inc. Clinical Trials and PubMed Articles about AIM Pharmakon, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of AIM Pharmakon, Inc. Companies in our database. You can also find out about relevant AIM Pharmakon, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record